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ABSTRACT Candida glabrata is an emerging human fungal pathogen that is frequently drug tolerant, resulting in
difﬁculties in treatment and a higher mortality in immunocompromised patients. The calcium-activated protein
phosphatase calcineurin plays critical roles in controlling drug tolerance, hyphal growth, and virulence in diverse
fungal pathogens via distinct mechanisms involving survival in serum or growth at host temperature (37  and
higher). Here, we comprehensively studied the calcineurin signaling cascade in C. glabrata and found novel and
uncharacterized functions of calcineurin and its downstream target Crz1 in governing thermotolerance, intracellular
architecture, and pathogenesis in murine ocular, urinary tract, and systemic infections. This represents a second
independent origin of a role for calcineurin in thermotolerant growth of a major human fungal pathogen, distinct
from that which arose independently in Cryptococcus neoformans. Calcineurin also promotes survival of C. glabrata
in serum via mechanisms distinct from C. albicans and thereby enables establishment of tissue colonization in
a murine systemic infection model. To understand calcineurin signaling in detail, we performed global transcript
proﬁling analysis and identiﬁed calcineurin- and Crz1-dependent genes in C. glabrata involved in cell wall bio-
synthesis, heat shock responses, and calcineurin function. Regulators of calcineurin (RCN) are a novel family of
calcineurin modiﬁers, and two members of this family were identiﬁed in C. glabrata: Rcn1 and Rcn2. Our studies
demonstrate that Rcn2 expression is controlled by calcineurin and Crz1 to function as a feedback inhibitor of
calcineurin in a circuit required for calcium tolerance in C. glabrata. In contrast, the calcineurin regulator Rcn1
activates calcineurin signaling. Interestingly, neither Rcn1 nor Rcn2 is required for virulence in a murine systemic
infection model. Taken together, our ﬁndings show that calcineurin signaling plays critical roles in thermotolerance
and virulence, and that Rcn1 and Rcn2 have opposing functions in controlling calcineurin signaling in C. glabrata.
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Candida glabrata is an emerging human fungal pathogen. Most
strains have reduced antifungal drug susceptibility, thus making treat-
ment challenging (Lagrotteria et al. 2007; Pfaller et al. 2011a). The
poor susceptibility of C. glabrata to antifungal drugs contributes to the
high mortality rate ( 50%) associated with C. glabrata candidemia
(Klevay et al. 2009). Resistance to echinocandins and azoles was most
prevalent among nosocomial bloodstream infection (BSI) isolates of
C. glabrata compared with other Candida species (Pfaller et al. 2011a).
Although C. albicans accounts for 48% of Candida BSIs, C. glabrata
ranked second, accounting for 18% of infections across multiple
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and North America (Pfaller et al. 2011b). Besides BSI, Candida species
also cause urinary tract infections (UTI). Fungal UTIs are often caused
by Candida species, which account for  10% of all nosocomial UTIs
related to indwelling catheters, with C. glabrata accounting for approx-
imately 15% of all Candida isolates (Kauffman et al. 2000; Lundstrom
and Sobel 2001). Surprisingly, a study performed by Phillips and
Karlowicz (1997) showed that 42% of hospital-acquired urinary tract
infections in neonatal intensive care units were caused by Candida
species. For Candida ocular infections, C. glabrata was previously
rarely seen; however, several recent studies report that C. glabrata
infects human corneas, especially in patients undergoing keratoplasty
(Caldwell et al. 2009; Djalilian et al. 2001; Kitzmann et al. 2009; Lee
et al. 2011; Tappeiner et al. 2009). The pathogenic mechanisms by
which C. glabrata causes ocular infections have not been reported.
Calcineurin is a calcium/calmodulin-dependent serine/threonine-
speciﬁc protein phosphatase that comprises a catalytic A (Cna1) and
a regulatory B calcium-binding subunit (Cnb1). Upon stimulation with
calcium, calmodulin associates with the calcineurin AB heterodimer,
stimulating phosphatase activity and converting signals to various
outputs by dephosphorylating its downstream targets. Upon dephos-
phorylation by activated calcineurin, the transcription factor Crz1 in
fungi or nuclear factor of activated T cells (NFAT) in mammals migrates
to the nucleus to regulate gene expression. Because active calcineurin is
an AB heterodimer, the loss of Cnb1 often results in destabilization of
Cna1 (Chen et al. 2010a). Calcineurin is essential for growth at elevated
temperatures in the human fungal pathogen Cryptococcus neoformans
(Odom et al. 1997) and the protozoan parasite Leishmania major
(Naderer et al. 2011), but it has not been demonstrated to have a role
in controlling thermotolerance of ascomycetes, including Candida spe-
cies. The intracellular architecture defects of C. neoformans and L. major
calcineurin mutants upon thermal stress have not been investigated. In
C. glabrata, calcineurin and Crz1 have been demonstrated to play func-
tions in antifungal drug tolerance, cellw a l li n t e g r i t y ,a n dv i r u l e n c ei n
a murine systemic infection model (Miyazaki et al. 2010). However, the
mechanism for C. glabrata calcineurin and Crz1 requirement in serum
survival and virulence in other murine infection models remains elusive.
The calcineurin- and/or Crz1-regulated transcriptome has been
investigated in Saccharomyces cerevisiae, C. albicans, Aspergillus fumiga-
tus,a n dt h er i c eb l a s tf u n g a lp a t h o g e nMagnaporthe oryzae (Karababa
et al. 2006; Kim et al. 2010; Malavazi et al. 2009; Yoshimoto et al.
2002). The regulation pattern of the transcriptome is diverged among
the four species. Because C. glabrata calcineurin and crz1 mutants
exhibited novel phenotypes distinct from these species in terms of
hypersensitivity to thermal stress, ER stress, and antifungal drugs,
microarray analyses to explore the targets of calcineurin and Crz1 in
C. glabrata will extend our understanding of calcineurin signaling.
Regulators of calcineurin (RCN) are a novel family of calcineurin
regulators found in eukaryotic cells. In S. cerevisiae, two regulators of
calcineurin (Rcn1 and Rcn2) have been demonstrated to control cal-
cineurin signaling. In C. albicans, the function of Rcn1 has been
associated with calcineurin signaling (Reedy et al. 2009). In C. glab-
rata, the functions of Rcn1 and Rcn2 in controlling calcineurin sig-
naling were recently reported (Miyazaki et al. 2011a). C. glabrata Rcn1
displayed both stimulatory and inhibitory effects, whereas Rcn2
showed only inhibitory activities on calcineurin signaling (Miyazaki
et al. 2011a). Interestingly, Rcn1 is required for micafungin and ﬂu-
conazole tolerance in addition to ER stress induced by tunicamycin
(Miyazaki et al. 2011a). However, the roles of Rcn1 and Rcn2 in
temperature sensitivity, pH response, and virulence remain unclear.
In mammals, the homolog of S. cerevisiae Rcn1 is named DSCR1/
Rcan1/calcipressin and is overexpressed in the brain of patients with
Down’s syndrome (Rothermel et al. 2003). In addition, Baek et al.
(2009) demonstrated that DSCR1, a negative regulator of calcineurin
located on chromosome 21 and thus present in three copies in
patients with Down’s syndrome, has antiangiogenic activity and inhib-
its tumor formation.
In this study, we comprehensively studied the roles of the calcineurin
signaling cascade in stress responses, antifungal drug tolerance, and
pathogenesis of C. glabrata. We demonstrated that C. glabrata calci-
neurin (Cna1 and Cnb1) and/or Crz1 are required for thermotolerance,
ER stress, pH homeostasis, and virulence in murine ocular, urinary
tract, and systemic infection models. In addition, global transcript pro-
ﬁling analysis revealed 30 calcineurin and Crz1-activated targets, which
explain, at least in part, the requirement of calcineurin signaling in cell
wall integrity, thermotolerance, and pathogenesis. Furthermore, we
demonstrated that a novel regulator of calcineurin 2 (Rcn2) is a down-
stream target of calcineurin and Crz1 and acts as a feedback inhibitor of
calcineurin signaling in response to calcium, whereas Rcn1 functions as
a positive regulator of calcineurin signaling.
MATERIALS AND METHODS
Ethics statement
Animals studies conducted in the Division of Laboratory Animal
Resources (DLAR) facilities at Duke University Medical Center (DUMC)
were handled with good practice as deﬁned by the United States Animal
Welfare Act and in full compliance with the guidelines of the DUMC
Institutional Animal Care and Use Committee (IACUC). The murine
systemic and urinary tract infection models were reviewed and approved
by the DUMC IACUC under protocol numbers A238-09-08 and A219-
08-08, respectively.
Murine ocular infection studies conducted at the animal house
facility of the Department of Microbiology and Parasitology, Univer-
sity of Perpetual Help–Dr. Jose G. Tamayo Medical University (UPH-
DJGTMU) were performed in accordance with the ARVO Statement
for the Use of Animals in Ophthalmic and Vision Research, the United
States Animal Welfare Act, and the Republic of the Philippines Animal
Welfare Act of 1998 (RA No. 8485), and in full conformity with the
guidelines set forth in the UPH-DJGTMU research manual. The pro-
tocol was formally approved by the UPH-DJGTMU institutional re-
view board after review by the Regional Institute for Tropical Medicine
Institutional Animal Care and Use Committee (RITM-IACUC) under
research protocol No. 010. All animal infection experiments were con-
ducted by properly trained personnel, including licensed veterinarians.
Yeast strains, media, and chemicals
Yeast strains used in this study are listed in Table 1. YPD (1% yeast
extract, 2% peptone, 2% glucose) liquid medium and agar (2%) and
SC (6.7 g yeast nitrogen base without amino acids, 1 · amino acid
stock, 20 g glucose, 20 g agar in 1 liter) media were used in this study.
YPD medium containing 100 mg/ml nourseothricin was used to select
transformants. YPD medium containing 150 mM HEPES buffered at
pH 2, 5, 8, or 9 was used to study pH tolerance. FK506 (Astellas
Pharma Inc.), cyclosporin A (CsA; LC Laboratories), sodium dodecyl
sulfate (SDS; Fisher), fetal bovine serum (Invitrogen), calcoﬂuor white
(CFW, ﬂuorescent brightener 28; Sigma), Congo red (Sigma), ﬂuco-
nazole (Bedford Laboratories), posaconazole (Sequoia Research Prod-
ucts Ltd.), ketoconazole (Sigma), voriconazole (Sigma), caspofungin
(Merck), micafungin (Astellas Pharma Inc.), anidulafungin (Pﬁzer
Inc.), tunicamycin (Sigma), and dithiothreitol (DTT; Sigma) were
added to the media at the concentrations indicated.
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The C. glabrata orthologs of the genes encoding C. albicans calci-
neurin subunits Cna1 and Cnb1 and the calcineurin target Crz1 were
identiﬁed by reciprocal BLAST searches between the two species, with
the reciprocal best BLAST hit orthologs in C. glabrata being the CNA1
(CAGL0L11110g), CNB1 (CAGL0L00605g), and CRZ1 (CAGL0M06831g)
genes. C. glabrata YPS5 (CAGL0E01771g, putative aspartyl prote-
ase) and RCN2 (CAGL0J04158g, regulator of calcineurin 2) were
identiﬁed by reciprocal BLAST searches using the S. cerevisiae ge-
nome and genes. The C. glabrata ortholog of C. albicans RCN1
(regulator of calcineurin 1) was identiﬁed by reciprocal BLAST
searches between C. glabrata and C. albicans, identifying the recip-
rocal best BLAST hit as C. glabrata RCN1 (CAGL0E06248).
Gene disruptions in C. glabrata
All deletion strains were generated from the prototrophic CBS138
(ATCC2001) background using the SAT1 ﬂipper (Reuss et al. 2004).
All primers used in strain construction are listed in Table S1. For the
CNA1 gene disruption, approximately 1 kb of the 59 (ampliﬁed with
primers JC49/JC50, Table S1)a n d3 9 (ampliﬁed with primers JC51/
JC52) noncoding regions (NCR) of the CNA1 ORF were PCR-ampliﬁed
from genomic DNA of the wild-type strain CBS138. The 4.2 kb
SAT1 ﬂipper sequence was ampliﬁed from plasmid pSFS2A (Reuss
et al. 2004) with primers JC17/JC18. The three PCR products were
treated with ExoSAP-IT (USB Corp.) to remove contaminating pri-
mers and dNTPs and then combined in a 1:3:1 molar ratio (59
CNA1NCR: SAT1 ﬂipper: 39 CNA1NCR) to generate the disruption allele
by overlap PCR using ﬂanking primers JC49/JC52, resulting in an
 6.2 kb 59CNA1NCR-SAT1 ﬂipper-39CNA1NCR CNA1 disruption al-
lele. The CNA1 gene was disrupted in the wild-type strain CBS138 by
transformation with 0.2 1.0 mg of gel-puriﬁed disruption cassette
DNA extracted with the Frozen-EZ Yeast Transformation Kit
(Zymo Research). Two independent nourseothricin-resistant cna1
mutants (YC67 and YC98, Table 1) were obtained from two sep-
arate transformations.
A similar approach was employed to disrupt the CNB1 and CRZ1
genes, with  1k bo ft h e5 9 and 39 noncoding regions used for ho-
mologous recombination. To generate the  6k bcnb1 disruption al-
lele, the overlap PCR DNA products 59 CNB1NCR (ampliﬁed with
primers JC134/JC135), SAT1 ﬂipper (ampliﬁed with primers JC17/
JC18), and 39 CNB1NCR (ampliﬁed with primers JC136/JC137) were
mixed in a 1:3:1 molar ratio and ampliﬁed with primers JC138/JC139
( 100 bp closer to the CNB1 ORF compared with JC134/JC137, re-
spectively, reserving primers JC134/JC137 for further integration con-
ﬁrmation). Two independent nourseothricin-resistant cnb1 mutants
(YC191 and YC193, Table 1) derived from two separate transforma-
tions were obtained. To generate the  6k bcrz1 disruption allele, 59
CRZ1NCR (ampliﬁed with primers JC142/JC143), SAT1 ﬂipper (ampli-
ﬁed with primers JC17/JC18), and 39 CRZ1NCR (ampliﬁed with pri-
mers JC144/JC145) were combined and ampliﬁed with primers JC146/
JC147 ( 100 bp closer to the CRZ1 ORF compared with JC142/JC145,
respectively). Two independent nourseothricin-resistant crz1 mutants
(YC267 and YC182, Table 1) derived from two separate transforma-
tions were obtained.
To disrupt the RCN1 gene, 59 RCN1NCR and 39 RCN1NCR were
ampliﬁed with primers JC459/JC460 and JC461/JC462, respectively.
JC463/JC464 primers were used to amplify the RCN1 disruption allele
via overlap PCR including three fragments: 59 RCN1NCR, SAT1 ﬂipper,
and 39 RCN1NCR. Two independent rcn1 mutants (YC553 and YC556)
were obtained. To disrupt the RCN2 gene, 59 RCN2NCR and 39 RCN2NCR
were ampliﬁed with primers JC441/JC442 and JC443/JC444, respectively.
JC445/JC446 primers were used to amplify the RCN2 disruption allele via
n Table 1 Candida glabrata and Cryptococcus neoformans strains
Strain Genotype Parent Reference
C. glabrata
CBS138 Prototrophic wild-type Clinical isolate Dujon et al. (2004)
YC67a cna1D::SAT1-FLP CBS138 This study
YC98a cna1D:: SAT1-FLP CBS138 This study
YC191b cnb1D::SAT1-FLP CBS138 This study
YC193b cnb1D::SAT1-FLP CBS138 This study
YC267c crz1D::SAT1-FLP CBS138 This study
YC182c crz1D::SAT1-FLP CBS138 This study
YC553d rcn1D::SAT1-FLP CBS138 This study
YC556d rcn1D::SAT1-FLP CBS138 This study
YC525e rcn2D::SAT1-FLP CBS138 This study
YC531e rcn2D::SAT1-FLP CBS138 This study
YC581 rcn2D::FRT YC531 This study
YC594 rcn2D::FRT rcn1D::SAT1-FLP YC581 This study
YC111 cna1D::FRT YC98 This study
YC535f cna1D::FRT rcn2D::SAT1-FLP YC111 This study
YC549f cna1D::FRT rcn2D::SAT1-FLP YC111 This study
YC504 cnb1D::FRT YC193 This study
YC599g cnb1D::FRT rcn2D::SAT1-FLP YC504 This study
YC601g cnb1D::FRT rcn2D::SAT1-FLP YC504 This study
YC502 crz1D::FRT YC182 This study
YC532h crz1D::FRT rcn2D::SAT1-FLP YC502 This study
YC534h crz1D::FRT rcn2D::SAT1-FLP YC502 This study
C. neoformans
H99 Prototrophic wild-type Clinical isolate Perfect et al. (1993)
KK1 cna1D::NAT H99 Kojima et al. (2006)
a,b,c,d,e,f,g,h
Two independently derived cna1, cnb1, crz1, rcn1, rcn2, cna1 rcn2, cnb1 rcn2,o rcrz1 rcn2 mutants, respectively.
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39 RCN2NCR. Two independent rcn2 mutants (YC525 and YC531) were
obtained.
To obtain the rcn1 rcn2 double mutant, we disrupted the RCN1
gene in the rcn2 mutant background (YC581, the SAT1 ﬂipper was
removed via culturing YC531 in YPD medium and replicating onto
nourseothricin-containing medium to conﬁrm the loss of SAT1 ﬂip-
per). To obtain the cna1 rcn2 (YC535 and YC549), cnb1 rcn2 (YC599
and YC601), and crz1 rcn2 (YC532 and YC534) double mutants, we
disrupted the RCN2 gene in SAT1 ﬂipper-free (methods described
above) cna1 (YC111), cnb1 (YC504), and crz1 (YC502) mutants,
respectively.
Transmission electron microscopy
Transmission electron microscopy (TEM) of C. glabrata was accom-
plished as follows. Cells were grown overnight in YPD at 24  and
washed twice with dH2O. Then 0.1 OD600 of cells (in 100 ml) was
spread on YPD agar plates and incubated for 24 hr at 24 ,3 7  ,a n d
40 . Cells were collected from agar plates by washing in 0.2 M sodium
cacodylate buffer (pH ¼ 6.8), collected by centrifugation ( 4,000 rpm,
3 min in a table-top centrifuge), resuspended in 2% glutaraldehyde
plus 0.05% malachite green oxalate in 0.1 M sodium cacodylate buffer,
and incubated at 4  for 2 days. Fixed cells were collected by centrifu-
gation, resuspended, washed with 0.1 M sodium cacodylate buffer,
centrifuged, supernatant removed, and post-ﬁxed with 0.8% K3Fe
(CN)6,1 %O s O 4, 0.1 M sodium cacodylate for 2 hr at room temper-
ature. The cells were washed twice with 0.1 M sodium cacodylate
buffer and stained with 1% tannic acid for 1 hr at room temperature.
Then cells were washed with 0.1% sodium cacodylate buffer for 5 min
followed by two washes in dH20f o r5 –10 min each and stained with
1% uranyl acetate in water overnight at 4 . Samples were washed in
molecular-grade distilled water, embedded in an agarose pellet, and
prepared for embedding. The cured peg was trimmed, sectioned, and
mounted on copper grids. Grids were post-stained prior to viewing.
Sections were viewed and imaged with a Philips/FEI CM 12 Trans-
mission EM (FEI Company, Hillsboro, OR) with Advanced Micros-
copy Techniques Corp. (AMT) 2K · 2K digital camera (Danvers,
MA) at the Duke University Department of Pathology.
Fluorescence microscopy
Cells were grown overnight in YPD at 24  and washed twice with
dH2O. Then 0.1 OD600 of cells (in 100 ml) was spread on YPD agar
plates and incubated for 24 hr at 24  and 37 . The Alexa Fluor 488
phalloidin (Cat #A12379; Life Technologies) staining of actin was
performed based on the protocol described by Adams and Pringle
(1991) with minor modiﬁcations. In brief, cells were spun and resus-
pended in 3.7% (vol/vol) formaldehyde in PBS for 1 hr, washed, and
resuspended in PBS (100 ml). Cells were then stained with 20 mlo f6 . 6
mM (or 0.2 U/ml) phalloidin stock for 1 hr in the dark. Stained cells
were washed ﬁve times with PBS, resuspended in 100 ml PBS in the
absence of mounting medium, and observed using the standard green
ﬂuorescence ﬁlter set.
Time-kill curve for strains exposed to ﬂuconazole,
micafungin, or serum
Cells were grown overnight at 24 ,w a s h e dt w i c ew i t hd H 2O, counted
with a hemocytometer, and then 5 · 106 cells were added to 5 ml of
fresh YPD medium 6 ﬂuconazole/micafungin or 5 ml of 100% fetal
bovine serum to achieve 106 cells/ml. Cells were cultured at 24  with
shaking at 250 rpm. The cells surviving after 0, 3, 6, 9, and 24 hr were
serially diluted onto YPD medium, and CFUs were counted after 48
hr of incubation at 24 . The experiments were performed in triplicate,
and data were plotted using Prism 5.03.
Culture growth, harvesting, and total RNA extractions
for microarray experiments
Strains were grown overnight at 24 , washed twice with dH2O, diluted
to 0.2 OD600/ml in YPD, and incubated for 3 hr at 24 . For wild-type
strains, cells in log-phase were diluted to 0.2 OD600/ml (10 ml) in YPD
in the presence or absence of FK506 (1 mg/ml) while cna1 (YC98) and
crz1 (YC182) mutants were diluted to 0.2 OD600/ml (10 ml) in YPD.
Following 3 hr of incubation at 37  with shaking at 250 rpm, the 10 ml
cultures were immediately added to 15 ml methanol (60%) chilled in
a dry ice-ethanol bath to stop cellular processes and RNase activity.
Cells were pelleted at 3000 rpm at 24 , ﬂash frozen with liquid N2,
and stored at 280  prior to total RNA extraction. The total RNAs
were extracted using the RNeasy Mini Kit (Qiagen). RNA quality was
assessed with the RNA 6000 Nano Kit of the Agilent Bioanalyzer 2100
to ensure RNA Integrity Number (RIN) scores $ 7.
Probe preparation, microarray hybridization,
and data analysis
Total RNA samples were reverse-transcribed to cDNA and labeled
with either Cy3 or Cy5, according to a modiﬁcation of the protocol
described by Wapinski et al. (2010). We employed a wheel hybrid-
ization design to compare all samples to each other with dye-swaps,
for four comparisons per sample on 10 microarrays per biological
replicate. The entire hybridization scheme was repeated for two bi-
ological replicates. After hybridization and washing per the manufac-
turer’s instructions, arrays were scanned using an Agilent scanner and
analyzed with Agilent’s Feature Extraction software V10.5.1. The me-
dian intensities of probes corresponding to a speciﬁcO R Fw e r eu s e d
to estimate the expression values for each gene. We then ﬁt linear
models to these gene expression data using the limma library of the R
Bioconductor Package (Gentleman et al. 2005), which computes fold
change, indicates the direction and quantity of the differential gene
expression between the samples, and provides summary statistics, in-
cluding T- and B-statistics and an adjusted P value that takes into
account the false discovery rate. For each comparison in each study,
Q-values were computed using the R package. Microarray results have
been deposited at NCBI Gene Expression Omnibus (http://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc=GSE31167).
Quantitative determination of expression
by real-time RT-PCR
DNase I (Turbo DNA-free; Ambion) was used to eliminate genomic
DNA contamination. One microgram of DNA-free total RNAs was
reverse-transcribed to cDNA by the Afﬁnity Script qPCR cDNA
Synthesis Kit (Agilent). PCR reactions of 25 ml included 10 ng cDNA
(in 10 ml), 12.5 mlo f2 · qPCR master mix (Brilliant SYBR Green Kit;
Agilent), 0.5 mlo f5mM forward primer, 0.5 mlo f5mMr e v e r s e
primer, 1.125 ml of nuclease-free H2O, and 0.375 mlo fR O Xd y e .
Quantitative PCR conditions were the following: 95 /10 min (dena-
turation); 95 /15 sec, 60 /1 min (40·, cycling stage); 95 /15 sec, 60 /
1m i n ,9 5  /15 sec (melting curve). Primers for probes were designed
using Primer3 (http://frodo.wi.mit.edu/primer3/) and are listed in Ta-
ble S1. The ABI PRISM 7900HT machine and StepOne v2.1 (Applied
Biosystems) were used to determine ΔΔCt and relative quantity (RQ).
The bar graphs of ACT1 normalized RQ compared with the wild-type
(CBS138) were created with Prism 5.03.
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Urinary tract infection model: Six- to eight-week-old female C3H/
HeJ mice (stock #000659, n ¼ 5 for each group) and C3H/HeOuJ
(stock #000635, n ¼ 8 for the group) from the Jackson Laboratory
were used in this study. C. glabrata strains were grown in 5 ml SD +
CAA medium (6.7 g yeast nitrogen base minus amino acids, 6 g
casamino acids, 20 g glucose in 1 L dH2O) overnight at 24 .C u l t u r e s
were washed twice with 10 ml of phosphate buffered saline (PBS) and
diluted to yield an infection inocula of 109 cells/ml after hemocytom-
eter counting. Prior to infection, mice were anesthetized with i.p. in-
jection of 100 ml of 5-fold diluted pentobarbital (ﬁnal concentration of
10 mg/ml in PBS). Thirty microliters (3 · 107 cells) were used to infect
mice via the urinary tract for 15 sec aided by polyethylene catheter
tubing (BD catalog #427400) and syringe (BD catalog #309659) with
30 G · 1/2 needle (BD catalog #305106). Bladder and kidney tissue
samples were harvested on day 7 and homogenized with 5 ml PBS for
5 s at 17,500 rpm (for kidneys) or at 24,000 rpm (for bladder) (Power
Gen 500; Fisher Scientiﬁc). Tissue homogenates were serially diluted
and 100 ml was plated onto YPD solid medium. The plates were
incubated at 24  for 72 hr to determine CFUs per organ. Appropriate
dilutions of the inocula were plated onto YPD at 24  f o r4 8h rt o
conﬁrm cell viability. All experimental procedures were carried out
according to NIH guidelines and Duke IACUC protocols for the
ethical treatment of animals.
Murine systemic infection model: Five- to six-week-old male CD1
mice from the Jackson Laboratory (n ¼ 10 for each group) were
utilized in this study. C. glabrata strains were grown in 5 ml liquid
YPD medium overnight at 24 . Cultures were washed twice with 10 ml
of phosphate buffered saline (PBS), and the cells were then resus-
pended in 2 ml of PBS. Cells were counted with a hemocytometer
and resuspended in an appropriate volume of PBS to obtain an in-
fection inocula concentration of 2 · 108 cells/ml. Two hundred micro-
liters (4 · 107 cells) were used to infect mice by lateral tail vein
injection. Appropriate dilutions of the cells were plated onto YPD solid
medium and incubated at 24  f o r4 8h rt oc o n ﬁrm cell viability. C.
glabrata–infected mice were sacriﬁced and dissected on day 7 post-
infection. The kidney and spleen tissues were removed, weighed, trans-
ferred to a 15 ml Falcon tube ﬁl l e dw i t h5m lP B S ,a n dh o m o g e n i z e d
for 5 s at 19,000 rpm (IKA T25; Cole-Parmer). Tissue homogenates
were serially diluted, and 100 ml was plated onto YPD solid medium.
T h ep l a t e sw e r ei n c u b a t e da t2 4   f o r4 8h rt od e t e r m i n eC F U sp e rg r a m
of organ. The identity of organ-recovered colonies was conﬁrmed by
PCR. All experimental procedures were carried out according to NIH
guidelines and Duke IACUC protocols for the ethical treatment of
animals.
Murine ocular infection model: Candida strains were grown in YPD
overnight at 25 . Cultures were washed three times with sterile PBS
(pH 7.4). Cells were diluted to a concentration of 106 CFU/5 ml. The
concentration was determined by using the spectrophotometer optical
density reading at a wavelength of 600 nm and multiplying it by
ac o n v e r s i o nf a c t o ro f1O D 600,e q u i v a l e n tt o3· 107 cells/ml. In-
oculum concentration was veriﬁe db yp l a t i n go nY P Df o r4 8h ra t2 5  .
For murine ocular infection, six- to eight-week-old outbred ICR
mice (20–28 g; Research Institute for Tropical Medicine, Alabang,
Philippines) were used in the experiment in accordance with the
ARVO Statement for the Use of Animals in Ophthalmic and Vision
Research. The previously described keratomycosis protocol (Chen
et al. 2011) was used for Candida infection with minor modiﬁcations
and was approved by the University of Perpetual Help Institutional
Review Board. Before the infection procedure, mice were anesthetized
by intravenous injection of Zoletil 50 (10–15 mg/kg body weight;
Virac, Australia) followed by topical application of proparacaine hy-
drochloride ophthalmic solution (Alcaine; Alcon-Couvreur, Belgium)
to the eyes. Once animals were anesthetized, the right eye was super-
ﬁcially scariﬁed in a grid-pattern by a sterile 25-gauge hypodermic
needle, and 5 mlo fCandida solution (106 CFU) was placed into each
eye. The inoculum was distributed uniformly by rubbing the eye for
few seconds with the eyelid. A mock-infection experiment was per-
formed using sterile PBS as a control. Disease severity of fungal ker-
atitis was assessed for 8 days with the aid of a dissecting microscope.
In this procedure, corneal involvement was assessed and scored
according to three parameters: (i) area of opacity, (ii) density of opac-
ity, and (iii) surface regularity. A grade of 0 to 4 was assigned based on
each of these criteria to yield a maximum score of 12.
Statistical analysis
Statistical analysis was conducted using Prism 5.03 software (Graph-
Pad, La Jolla, CA). The signiﬁcance of differences in fungal burden
was determined using one-way ANOVA and Dunnett’s multiple com-
parison tests. For optimal serum growth and real-time RT-PCR, the
signiﬁcance of differences was determined by one-way ANOVA and
Bonferroni’s multiple comparison tests. For shrunken cell percentage
and murine ocular infection, the Student unpaired t-test was used to
determine signiﬁcance. P , 0.05 was considered signiﬁcant.
RESULTS AND DISCUSSION
The calcineurin pathway plays a critical role
in thermotolerance in C. glabrata
Fungal pathogens must adapt to elevated temperatures and other
environmental stresses to successfully infect their mammalian hosts.
How these environmental cues are sensed is not clear. In the human
fungal pathogen C. neoformans, calcineurin mutants are unable to
grow at 37  and as a result are avirulent in an animal model of
cryptococcal meningitis (Odom et al. 1997). In the protozoan parasite
L. major, a calcineurin mutant (cnb) loses viability at 34  and thus fails
to survive in mice (Naderer et al. 2011). To date, a requirement of
calcineurin for high-temperature growth has not been reported in
ascomycetes, including species such as S. cerevisiae (Cyert et al.
1991), C. albicans (Bader et al. 2006), A. fumigatus (Steinbach et al.
2006), and M. oryzae (Choi et al. 2009). Here, we demonstrate that
high-temperature growth in C. glabrata is controlled by calcineurin
and Crz1. C. glabrata calcineurin mutants (cna1 and cnb1)e x h i b i t e d
a temperature-sensitive (ts) phenotype at 40 ,w h e r e a scrz1 mutants
exhibited intermediate growth between the wild-type strain and calci-
neurin mutants (Figure 1A), suggesting the calcineurin pathway gov-
erns growth at elevated temperature. The growth of the wild-type
strain in medium containing the calcineurin inhibitors FK506 or
cyclosporin A (CsA) at 40  phenocopies the ts growth of calcineurin
mutants in the absence of calcineurin inhibitors (Figure 1A). We
observed that cna1 and cnb1 mutants, and the wild-type strain in
the presence of FK506 or CsA, exhibited slight growth defects at
37  but not at 24  (Figure 1A). The growth defects of calcineurin
mutants were not simply due to a general reduced rate of growth
because wild-type strain and calcineurin pathway mutants had similar
growth kinetics at 24  (Figure 1B). Calcineurin mutants were not
viable after 48 hr growth at 40  and could not be rescued after transfer
to 24  for 48 hr (Figure 1C). When cells were growing in log phase at
40 , cna1 and cnb1 mutants exhibited a signiﬁcantly shrunken cell
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tion, respectively, compared with the wild-type (1.7 6 1.5%), P #
0.002; Figure 1D]. The shrunken cell morphology was also observed in
wild-type cells at 40  in the presence of FK506 or cyclosporin A
(Figure S1). The crz1 mutants showed an intermediate proportion
of shrunken cells (29.3 6 9.4%) compared with the wild-type and
calcineurin mutants (Figure 1D). Interestingly, the growth defects of
the calcineurin mutants at 40  were rescued by the presence of an
osmotic stabilizer (1 M sorbitol; Figure 1E, left panel), which is in
contrast to C. neoformans calcineurin mutant for which the osmotic
stabilizer did not rescue the growth of the mutant at 37  (Figure 1E,
right panel). Our data suggest a novel role for the calcineurin pathway
in controlling thermal stress response of C. glabrata and a convergent
role of calcineurin in promoting high-temperature growth of C. glab-
rata and C. neoformans.
The intracellular architecture of calcineurin mutants upon thermal
stress in C. neoformans and L. major remains elusive. Here, we ex-
amined cell structures of C. glabrata wild-type and calcineurin path-
way mutants upon growth at 24 ,3 7  , and 40  via transmission
electron microscopy. C. glabrata calcineurin and crz1 mutants exhibit
abnormal cell structures compared with the wild-type at 37  or above
(Figure 2 and Figure S2), but not at 24  (data not shown). Calcineurin
and crz1 mutants exhibit irregular plasma membrane structures (red
arrowheads in Figure 2, E, H, and K) at 37 , whereas the wild-type
strain shows an intact and regular plasma membrane structure (Figure
2B). A similar disruption of the plasma membrane has not been
reported for S. cerevisiae calcineurin mutants. Because actin forms
patches associated with the plasma membrane in S. cerevisiae (Doyle
and Botstein 1996; Waddle et al. 1996), we examined whether C.
glabrata calcineurin mutants might exhibit defective cortical actin
patch structures. However, we found no defects in forming cortical
actin patches based on phalloidin staining of calcineurin mutant cells
at 37  (Figure S3). Calcineurin and crz1 mutants show fewer budding
cells at 37  compared with the wild-type (data not shown), suggesting
a reduced growth rate or cell-cycle arrest of calcineurin pathway
mutants. When grown at 40  for 24 hr, calcineurin mutants could
not be recovered due to cell death, whereas crz1 mutants exhibit
misshapened organelles (Figure S2C) and irregular plasma membrane
structures (Figure S2D) compared with the wild-type. Altogether, our
data suggest that the calcineurin pathway is required for maintaining
intact plasma membrane structure in C. glabrata.
To determine whether calcineurin was required for thermotol-
erance in all C. glabrata strains, we tested the growth of 19 clinical C.
glabrata isolates at elevated temperatures in the presence of FK506 or
CsA. We found that 16% (3/19) of C. glabrata clinical isolates exhibit
temperature sensitivity in the presence of a calcineurin inhibitor (Fig-
ure S4), suggesting that the requirement of calcineurin at elevated
temperatures has been evolutionarily diverged in distinct isolates of
the species. One of the 3 clinical isolates that exhibited temperature
sensitivity in the presence of FK506 or CsA was the type strain and
genome-sequenced reference strain CBS138, used as the parental wild-
type strain in this study. It is possible that a speciﬁc mutation occurred
in the genome of the C. glabrata ancestor that resulted in reduced
ﬁtness, such as a temperature-sensitive response to calcineurin inhib-
itors secreted by the bacterium Streptomyces tsukubaensis in the soil
(Goto et al. 1987). Because most C. glabrata strains did not exhibit the
ts phenotype in response to calcineurin inhibitors, it suggests that
additional modiﬁer mutations might be present that suppress the ts
phenotype. Further studies that isolate high-temperature–resistant
mutants from C. glabrata CBS138 in the presence of a calcineurin
inhibitor and screening suppressors or sequencing the whole ge-
nome will shed light on the roles of C. glabrata calcineurin in
thermotolerance.
Calcineurin contributes to tissue colonization
in a murine urinary tract infection model
Candida species account for 10–15% of all nosocomial urinary tract
infections related to indwelling catheters (Lundstrom and Sobel 2001).
C. albicans (52%), C. glabrata (16%), C. tropicalis (8%), and C. para-
psilosis (4%) were the major Candida species found in the urine of 861
patients with funguria (Kauffman et al. 2000). Recently, Silva et al.
(2010) reported that C. glabrata strains exhibited a better ability to
colonize silicone surfaces in the presence of urine than C. tropicalis or
C. parapsilosis, which may explain why C. glabrata is an emerging
pathogen in hospitalized and catheterized patients. C. glabrata epithe-
lial adhesin triple knockout mutant (epa1,6,7) has been demonstrated
to have a decreased ability to colonize the bladder in the murine
urinary tract infection model (Cormack et al. 1999). However, other
factors that might contribute to urinary tract infections due to C.
glabrata are unclear. We demonstrated that calcineurin contributed
to murine urinary tract infections. C. glabrata cna1 and cnb1 mutants
exhibited a 7.5-fold (P , 0.001) and 3.7-fold (P , 0.01) reduced
fungal burden in the kidneys, respectively, whereas crz1 mutants
exhibited no difference compared with the wild-type strain (Figure
3A). Nevertheless, we were unable to determine the fungal burden in
bladders when we used the C3H/HeJ inbred mouse strain, which
serves as a vesico-ureteric reﬂux (VUR) model (Murawski et al.
2010) and is the only mouse model that has worked for this purpose
in our laboratory. VUR is deﬁned by the retrograde passage of path-
ogen from the bladder into the ureters and pelvis of the kidneys. The
percentage of VUR with the C. glabrata infection in C3H/HeJ mice
was 91.2% (31/34), indicating that most C. glabrata cells migrated
from the bladder to the kidneys; therefore, the fungal burden in the
bladders remained very low due to the nature of this mouse model
(Figure S5A). The mouse strains CD1 and CBA/J have been used to
determine the fungal burden of C. glabrata in bladders and kidneys,
but the model was unsuccessful due to poor colonization of the blad-
der and kidneys with percentages of VUR of 34% and 50%, respec-
tively (data not shown).
Mouse TLR4 is not required for protection from
C. glabrata urinary tract infection
C3H/HeJ mice have a Toll-like receptor 4 (TLR4) mutation. TLR4 is
a type of pattern recognition receptor (PRR) that recognizes lip-
opolysaccharides from Gram-negative bacteria and initiates innate
immunity. Recently, Leal et al. (2010) showed that killing of A. fumi-
gatus was reduced in a TLR4(2/2) murine keratitis model, suggesting
that TLR4 is required for A. fumigatus infection. In C. albicans,t h e
role of mammalian TLR4 for Candida recognition or infection varies
in different studies (Gil and Gozalbo 2006; Netea et al. 2006) and
appears to be dependent upon the C. albicans isolates tested (Netea
et al. 2010). However, the role of TLR4 against C. glabrata infection is
unclear. Our data demonstrated that C. glabrata can establish infec-
tion in kidneys of TLR4(2/2) C3H/HeJ mice following urinary tract
inoculation but not in other TLR4(+/+) CD1 or CBA/J mice. To de-
termine whether TLR4 has role in C. glabrata infection, we used TLR4
(+/+) C3H/HeOuJ mice, which have a similar genetic background as
C3H/HeJ mice. Our experiments showed that the C. glabrata wild-
type strain CBS138 exhibited a similar fungal burden in the kidneys
and bladders of TLR4(+/+) C3H/HeOuJ and TLR4(2/2)C 3 H / H e J
mice in a urinary tract infection model (Figure 3B), suggesting that
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infection model. Therefore, the differential responses to C. glabrata
urinary tract infection in CD1, CBA/J, and C3H/HeJ mice might be
attributable to speciﬁc mouse strains but not to the TLR4 mutation.
Calcineurin and Crz1 inﬂuence tissue colonization
in a murine systemic infection model
The requirement of C. albicans calcineurin for mammalian virulence
depends on the speciﬁcn i c h e( B a d e ret al. 2006). For example, calci-
neurin controls virulence in murine systemic infections, but not in vag-
inal or pulmonary infection models (Bader et al. 2006). In addition,
fungal calcineurin uses different pathogenesis mechanisms to cause infec-
tions in the host depending on the infection location (Chen et al. 2010a).
We tested whether C. glabrata calcineurin is required for murine systemic
infections. Unlike C. albicans and C. dubliniensis, C. glabrata preferen-
tially colonizes the spleen rather than kidney tissues. In splenic tissues,
both cna1 and cnb1 mutants exhibited a 3.7-fold reduced fungal burden
(P , 0.0001), whereas crz1 mutants had a 2.1-fold reduced fungal burden
(P , 0.01) (Figure 3C) compared with the wild-type strain. The results of
t h ec a l c i n e u r i nm u t a n t si ns p l e e nt i ssues were similar to those reported
by Miyazaki et al. (2010). However, we found that crz1 mutants exhibited
reduced fungal burden in the spleen, while Miyazaki and colleagues
reported no difference. The differential role of crz1 m u t a n t si nc o l o n i z i n g
the spleen between the two groups might be due to differences in mouse
strains, C. glabrata strains, or experimental procedures. In kidney tissues,
cna1 and cnb1 mutants exhibited 2.5-fold (P ¼ 0.05) and 3.9-fold (P ,
0.01) reduced fungal burdens compared with the wild-type strain,
whereas crz1 mutants showed a 2.3-fold reduced fungal burden (P ,
0.05) compared with the wild-type strain. Our results of fungal burden in
the kidneys were consistent with those reported by Miyazaki et al. (2010).
Taken together, C. glabrata calcineurin and Crz1 contribute to virulence
in a murine systemic infection model.
Figure 1 Calcineurin pathway is required for thermotol-
erance in C. glabrata. (A) Pharmacological inhibition of
calcineurin phenocopies genetic deletion of calcineurin.
Cells were grown overnight in YPD at 24 , 5-fold serially
diluted, and spotted onto YPD medium containing
FK506 or cyclosporin A (CsA), and incubated at the in-
dicated temperatures for 48 hr. Strains tested were wild-
type (CBS138), cna1 mutants (YC67 and YC98), cnb1
mutants (YC191 and YC193), and crz1 mutants (YC267
and YC182). (B) The growth kinetics of C. glabrata wild-
type and mutant strains at 24 . Cells were grown over-
night at 24 , washed twice with dH2O, diluted to 0.2
OD/ml in fresh liquid YPD medium, and incubated at
24  with shaking at 250 rpm. The OD600 of cultures was
measured at 0, 3, 6, 9, 24, and 30 hr. The experiments
were performed in triplicate, and data were plotted us-
ing Prism 5.03. Strains tested were wild-type (CBS138),
cna1 mutant (YC98), cnb1 mutant (YC193), and crz1 mu-
tant (YC182). (C) Calcineurin is required for survival at
40 . Cells were grown overnight in YPD at 24 , 5-fold
serially diluted, spotted onto YPD. The plate was incu-
bated at 40  for 48 hr, then transferred to 24  for 48 hr
incubation. (D) Calcineurin mutant cells exhibit
a shrunken cell morphology at 40 . Cells were grown
overnight in YPD medium at 24 , washed twice with
dH2O, diluted to 0.5 OD600/ml in fresh liquid YPD me-
dium, and incubated at 24  or 40  with shaking at 250
rpm for 4 hr. Strains tested were wild-type (CBS138),
cna1 mutant (YC98), cnb1 mutant (YC193), and crz1 mu-
tant (YC182). The images were taken at 100·. Scale
bar ¼ 5 mm. (E) An osmotic stabilizer rescued tempera-
ture-sensitive phenotypes of calcineurin mutants from
C. glabrata, but not from C. neoformans. Cells were
grown overnight in YPD at 24 , 5-fold serially diluted,
spotted onto YPD medium containing 1 M sorbitol, and
incubated at the temperatures indicated for 48 hr. C.
neoformans strains tested were wild-type (H99) and
cna1 mutant (KK1).
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murine ocular infection
C. glabrata is an uncommon yeast pathogen in ocular infections,
but it has recently been reported with increasing frequency in post-
keratoplasty patients, often resulting in ocular morbidity, including
loss of vision (Al-Assiri et al. 2006; Caldwell et al. 2009; Grueb
et al. 2006; Muzaliha et al. 2010). However, the mechanisms of
ocular infection due to C. glabrata have not been studied. We used
a murine ocular infection model to investigate the roles of the C.
glabrata calcineurin pathway in ocular pathogenesis. The C. glab-
rata wild-type strain CBS138 established an ocular infection in 43%
(6/14) of the immunocompetent CD1 mice, whereas the C. albicans
wild-type strain SC5314 established infection in 100% (12/12) of
the mice (Figure 4). Ocular infections due to C. albicans were
signiﬁcantly more severe than those caused by C. glabrata at all
time points (P , 0.05; Figure S5B), representing the ﬁrst compar-
ison between C. albicans and C. glabrata in a murine ocular
infection model. C. glabrata cna1, cnb1,a n dcrz1 mutants were
unable to establish infection, suggesting that the calcineurin path-
way controls ocular pathogenesis.
C. glabrata w i l d - t y p es t r a i nC B S 1 3 8c a ne stablish murine ocular in-
fection in immunocompetent mice, which is in contrast to the inability
of C. dubliniensis to cause ocular infection in an immunocompetent
mouse model (Chen et al. 2011). Because C. albicans successfully infected
the cornea of immunocompetent mice (100%), we conclude that the
relative ability of the three Candida species to cause murine ocular in-
fection is C. albicans . C. glabrata . C. dubliniensis.
Calcineurin is essential for ER stress tolerance and cell
wall integrity in C. glabrata
A straightforward explanation for the attenuated virulence of calci-
neurin mutants is their growth defects (plasma membrane disruption
and slower growth) at body temperature ( 37 ). However, it is possi-
ble that calcineurin is involved in other mechanisms necessary for the
establishment and maintenance of infections. The maintenance of the
ER stress response is required for successful infection by fungal
Figure 2 TEM images of C. glabrata grown at
37 . Calcineurin mutants (cna1 and cnb1) and
crz1 mutants display aberrant cell membrane
structure (red arrowheads) compared with
wild-type. (A–C) wild-type (CBS138). (D–F)
cna1 mutant (YC98). (G–I) cnb1 mutant
(YC193). (J–L) crz1 mutant (YC182). The
cna1 and cnb1 mutants display the most ab-
errant phenotypes at 37  and could not be
recovered from 40  for TEM analysis. Scale
bar ¼ 500 nm (A, D, G, J) and 100 nm (B,
C, E, F, H, I, K, L). Column one comprises
low-magniﬁcation images displaying the
overall cell structure. Column two displays
a second image, at higher magniﬁcation, rep-
resentative of the cell membrane structure of
the cell in column one. Column three displays
a high-magniﬁcation view of the cell mem-
brane of one additional cell.
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the ER stress response and unfolded protein response (UPR), is
required in A. fumigatus for virulence in a murine invasive asper-
gillosis model (Richie et al. 2009). The UPR is activated to induce
molecular chaperones involved in protein folding upon the accu-
mulation of unfolded or misfolded proteins in the lumen of the ER.
Recently, Cheon et al. (2011) demonstrated that the C. neoformans
UPR pathway (IRE1 and HXL1) is essential for ER stress tolerance,
thermotolerance, and virulence in a murine intranasal infection
model. Because C. glabrata calcineurin mutants exhibit similar
stress responses to those of C. neoformans UPR pathway mutants,
it is possible that calcineurin might function together with the UPR
pathway to orchestrate multiple phenotypes in C. glabrata.T h u s
far, it is unclear whether the ER stress response is required for
virulence of C. glabrata.
A link between ER stress response and calcineurin is known in S.
cerevisiae (Bonilla et al. 2002), in the plant fungal pathogen Ustilago
hordei that causes covered smut of barley (Cervantes-Chavez et al.
2011), and in the protozoan parasite L. major, which causes leishman-
iasis in humans (Naderer et al. 2011). For example, U. hordei cna1 and
cnb1 mutants were hypersensitive to the chemical ER stressors tuni-
camycin (TM; blocks the synthesis of N-linked glycoproteins in the
ER) and dithiothreitol (DTT; disrupts the formation of disulﬁde bonds
and leads to retention of proteins in the ER) (Cervantes-Chavez et al.
2011). Because Crz1, a downstream target of calcineurin, has not
been identiﬁed in U. hordei or other basidiomycetes, it will be
interesting to investigate whether this ER stress response is medi-
ated by Crz1. We demonstrated that the ER stress response is
associated with calcineurin and Crz1 function in C. glabrata.T h e
cna1 and cnb1 mutants exhibited hypersensitive growth on media
containing TM or DTT, whereas crz1 mutants showed intermedi-
ate phenotypes between the wild-type strain and calcineurin
mutants (Figure 5A).
There is limited information linking ER stress and cell wall
integrity in fungi. In S. cerevisiae, ER stress has been demonstrated to
activate cell wall integrity (CWI) signaling via mitogen-activated pro-
tein kinase Slt2/Mpk1 (Krysan 2009; Scrimale et al. 2009). In Candida,
Cryptococcus,a n dAspergillus species, calcineurin is required for cell
wall integrity (Chen et al. 2010a). Here, we showed that calcineurin
but not crz1 mutants are hypersensitive to agents that damage the cell
wall or membrane, including calcoﬂuor white, Congo red, and SDS at
24  (Figure 5, A and B). In accord with TEM images (Figure 2),
calcineurin and crz1 mutants are hypersensitive to the membrane-
damaging agent SDS at 37  (Figure 5B). The cell wall integrity of
Candida species has been demonstrated to be required for virulence
in murine systemic infection models (Chen et al. 2010b). Thus, the
requirement of calcineurin in cell wall/membrane integrity may affect
the pathogenicity of C. glabrata.
Figure 3 C. glabrata calcineurin plays critical roles in
tissue colonization of murine urinary tract and systemic
infection models. (A) The fungal burden in the kidneys
was determined at day 7 after challenge with 3 · 107
cells (in 30 ml) via urinary tract infection. Five female
C3H/HeJ mice per strain (except four mice with one
crz1 mutant due to a death following anesthesia with
pentobarbital) were used. The P value between wild-
type (WT) and mutants is shown. Strains tested were
wild-type (CBS138); cna1 mutants (YC67 and YC98);
cnb1 mutants (YC191 and YC193); and crz1 mutants
(YC267 and YC182). (B) Mouse TLR4 is not required
for protection from C. glabrata urinary tract infection.
The fungal burden in the kidneys and bladders was de-
termined at day 7 after challenging C3H/HeJ (group of
ﬁve animals) or C3H/HeOuJ (group of eight animals)
mice with 3 · 107 C. glabrata wild-type (CBS138) cells
via urinary tract infections. The P value between C3H/
HeJ and C3H/HeOuJ mice is shown. (C) The fungal
burden in the spleen and kidneys was determined at
day 7 after challenge with 4 · 107 cells (in 200 ml) via
lateral tail vein injection. Ten male CD1 mice per strain
were used. The P value between WT and mutants is
shown.
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How fungal pathogens sense environmental pH changes is central to
virulence. In C. albicans, calcineurin appears to be required for pH
homeostasis (Kullas et al. 2007). However, the requirement of calcineurin
for pH homeostasis had not been studied in C. glabrata.W ef o u n dt h a t
cna1 and cnb1 mutants were hypersensitive to both acidic (pH 2) and
alkaline (pH 8) conditions (Figure 5C), whereas crz1 mutants exhibited
sensitivity similar to the wild-type, suggesting pH homeostasis is gov-
erned solely by calcineurin and not Crz1 in C. glabrata.
The C. glabrata GPI-anchored aspartyl protease Yps1 has been
demonstrated to be required for pH homeostasis (Bairwa and Kaur
2011) and virulence in a murine systemic infection model (Kaur et al.
2007). Miyazaki et al. (2011b) showed that transcription of CgYPS1
was regulated by calcineurin in C. glabrata. On the basis of previous
studies and ours, we suggest that calcineurin may control pH homeo-
stasis and virulence via Yps1 in C. glabrata. The pH of mouse urine is
about 5.3, and the pH of blood is nearly 7.2. Because calcineurin is
essential for growth at pH 2 and pH 8 but not pH 5 (Figure 5), we
suggest that the requirement of calcineurin in pH homeostasis may
play a limited role in causing infections.
Optimal growth in serum is controlled by calcineurin
but not Crz1 in C. glabrata
The survival and proliferation of fungal pathogens in host serum are
essential for a successful bloodstream infection. The growth defects of
calcineurin mutants in serum have been linked to attenuated virulence
of C. albicans and A. fumigatus (Blankenship and Heitman 2005;
Steinbach et al. 2007). For example, C. albicans calcineurin is required
for survival in calcium stress, and A. fumigatus calcineurin is required
for survival in the low-phosphate stress of serum (Chen et al. 2010a).
Because C. glabrata calcineurin mutants exhibited attenuated viru-
lence in a murine systemic infection, we investigated whether serum
inhibits the growth of C. glabrata calcineurin mutants. Calcineurin,
but not crz1, mutants are hypersensitive to serum-containing medium
(Figure 6A). We also performed a time-kill assay to determine
whether serum is lethal to calcineurin mutants. C. glabrata calcineurin
mutants were not killed in serum, but their growth was arrested,
whereas the growth of the crz1 mutant in serum is similar to that
of the wild-type strain (Figure 6B), suggesting the growth arrest
in serum was linked to calcineurin but not to Crz1. The addition of
the calcium chelators bis(o-aminophenoxy)ethane tetraacetic acid
(BAPTA) or ethylene glycol tetraacetic acid (EGTA) to serum did
not rescue the growth of calcineurin mutants (data not shown), in-
dicating C. glabrata employs calcineurin in a mechanism distinct from
C. albicans to proliferate in serum. In a liquid growth assay in a poly-
styrene plate, calcineurin mutants exhibited reduced growth in serum
compared with the wild-type strain or crz1 mutants, whereas in con-
trol YPD medium alone there was no difference in growth between
Figure 4 Calcineurin pathway mutants are unable to establish murine
ocular infections. Representative clinical photographs of corneas of
immunocompetent ICR mice 8 days after challenge with 106 cells of C.
glabrata wild-type (Cg WT; CBS138), cna1 (YC98), cnb1 (YC193), crz1
(YC182), C. albicans wild-type (Ca WT; SC5314), or mock inoculation
with PBS. All strains were grown overnight at 25  and diluted with PBS
prior to topical application. Fungal keratitis, indicated by blue arrow-
heads, was seen only in animals infected with C. glabrata CBS138
(43%) or C. albicans SC5314 (100%). No infection with the calcineurin
pathway mutants resulted in visible keratitis in mice.
Figure 5 Calcineurin controls ER stress tolerance, cell wall integrity, and
pH homeostasis in C. glabrata. (A) Calcineurin mutants are hypersensi-
tive to ER stress chemicals and cell wall integrity-damaging agents. Cells
were grown overnight in YPD at 24 , 5-fold serially diluted, and spotted
onto YPD medium containing tunicamycin (TM), dithiothreitol (DTT),
calcoﬂuor white (CFW), or Congo red (CR), and incubated at 24  for
48 hr. (B) Calcineurin and crz1 mutants are hypersensitive to the cell
membrane integrity-damaging agent sodium dodecyl sulfate (SDS).
Cells were grown overnight in YPD at 24 , 5-fold serially diluted, and
spotted onto YPD medium containing SDS and incubated at indicated
temperatures for 48 hr. (C) Calcineurin is required for growth at acidic
and alkaline environments. Cells were grown overnight in YPD at 24 ,5 -
fold serially diluted, and spotted onto YPD medium containing 150 mM
HEPES buffered at pH 2 or 5. For pH 8 medium, YPD was buffered with
150 mM pH 9 HEPES (85 ml of YPD plus 15 ml of 1M HEPES at pH 9)
due to slightly acidic YPD medium. The pHs of solid media were con-
ﬁrmed with pH indicator strips.
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also support the roles of calcineurin in a murine systemic infection
model because attenuated virulence of the calcineurin mutants may be
in part due to growth arrest in serum.
Antifungal drug susceptibility is controlled
by calcineurin and Crz1 in C. glabrata
C. glabrata is notorious for its antifungal drug tolerance, which con-
tributes to difﬁculty in treating infections associated with this species.
Our studies demonstrated that calcineurin contributes to virulence in
murine urinary tract, systemic, and ocular infections due to C. glab-
rata.T h u s ,C. glabrata calcineurin is a drug target worthy of investi-
gation. Calcineurin mutants (cna1 and cnb1) are hypersensitive to the
azoles ﬂuconazole, posaconazole, and ketoconazole (Figure 7A), and
to the echinocandins micafungin, caspofungin, and anidulafungin
(Figure 7B). In disk diffusion assays, calcineurin mutants exhibit larger
and clearer zones of inhibition in the presence of ﬂuconazole or
micafungin than the wild-type strain (Figure 7, C and D). To conﬁrm
the fungicidal effects of the drugs on calcineurin mutants, we per-
formed time-kill assays. Fluconazole exhibited fungicidal activity at
100 mg/ml, but not at 10 mg/ml, against calcineurin mutants over
24 hr of incubation (Figure 7E). At a concentration of 8 ng/ml, mica-
fungin showed fungicidal activity against calcineurin mutants but not
the wild-type strain (Figure 7F). Taken together, our data suggest that
combination therapy with a calcineurin inhibitor and ﬂuconazole or
micafungin may improve the treatment outcome of C. glabrata
infections.
Interestingly, crz1 mutants showed differential responses to azoles
and echinocandins. Unlike the intermediate hypersensitivity pheno-
types of crz1/crz1 mutants in C. albicans and C. dubliniensis (Chen
et al. 2011), C. glabrata crz1 mutants exhibit hyperresistance to azoles
(Figure 7A), suggesting that Crz1 might repress genes involved in
azole tolerance in C. glabrata. In response to echinocandins, crz1
mutants showed an intermediate phenotype between the wild-type
and the calcineurin mutants (Figure 7B), suggesting that echinocandin
tolerance is mediated by a calcineurin-dependent Crz1 pathway.
Genome-wide analysis of calcineurin- and
Crz1-dependent targets in C. glabrata
To better understand the multiple phenotypes of calcineurin pathway
mutants and to identify calcineurin pathway–regulated genes in C.
glabrata, we compared the genome-wide transcriptome proﬁle of a
wild-type strain with an FK506-treated wild-type strain, a cna1 mu-
tant, and a crz1 mutant (Figure 8A). We expected that the FK506-
treated wild-type strain would have a similar expression proﬁle to that
of the cna1 mutant. The genes regulated by FK506 largely overlapped
(90%, 180/200) with differentially expressed genes in a cna1 mutant
(Figure 8B). By looking at calcineurin-upregulated and calcineurin-
downregulated genes, the FK506 group overlapped 96% (107/112) and
83% (73/88), respectively, with the cna1 mutant (Figure 8B). Interest-
ingly, 38% (33/87) of Crz1-dependent genes are Cna1-independent
(Figure 8B), indicating that proteins other than calcineurin might
regulate Crz1 and result in differential expression proﬁles compared
with the calcineurin-dependent Crz1 pathway. The genes regulated by
FK506 exhibited 29% (32/112, upregulated) and 3% (3/88, downregu-
lated) overlap, respectively, with differential expressed genes in a crz1
mutant (Figure 8B), suggesting a strong correlation between FK506-
treated wild-type and cna1 mutant, but not with the crz1 mutant. In
addition, FK506 treatment of wild-type cells resulted in differential
expression of 20 genes (Table S2) distinct from those in the cna1
mutant, including genes encoding plasma membrane ATP-binding
cassette (ABC) multidrug transporters (PDR5, PDR15,a n dYOR1),
the bile acid transporter YBT1, and the transcription factor INO2,
possibly due to FK506 inhibition of FKBP12 or other FKBPs or to
direct action on multidrug resistance (MDR) pumps.
Because the requirement of calcineurin in C. glabrata is different
from C. albicans in terms of thermal stress tolerance and optimal
serum growth, it is of interest to explore the calcineurin and Crz1
targets in C. glabrata.W ei d e n t i ﬁed 34 genes that are regulated by
Figure 6 Calcineurin, but not Crz1, is required for optimal growth in
serum. (A) Cells were grown overnight in YPD at 24 , 5-fold serially
diluted, spotted onto synthetic complete (SC) medium 6 40% fetal
bovine serum, and incubated at 24  for 4 days. (B) Time-killing curve of
wild-type (CBS138), cna1 (YC98), cnb1 (YC193), and crz1 (YC182)
strains grown in 100% serum. Cells surviving at 24  with shaking at
250 rpm after 0, 3, 6, 9, and 24 hr were serially diluted onto YPD
medium, and CFUs were counted after 48 hr incubation at 24 . The
data are represented as means 6 SD from triplicate experiments. (C)
Calcineurin mutants cannot proliferate as well as the wild-type strain or
crz1 mutant in serum. Two microliters of 1 OD600/ml cells was added
to 100 ml of 100% serum or YPD medium in 96-well polystyrene plates,
and the OD600 was measured after stationary incubation at 24  for 24
hr. The data are represented as means 6 SD from triplicate experi-
ments. Asterisk represents P , 0.001 compared with the wild-type.
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involved in cell wall biosynthesis (YPS5, YPS1, YSR3, YPC1, PIR1,
HOR7,a n dNTE1), heat shock protein responses (SBA1 and GRE2),
and calcineurin regulation (RCN2). Among 34 genes, 30 genes are
upregulated and 3 genes are downregulated by the calcineurin path-
way, whereas 1 gene (LIP5) is upregulated in the FK506-treated wild-
type and cna1 mutant and is downregulated in the crz1 mutant (Figure
9A). Although the transcription levels of another calcineurin regulator
(RCN1) and calcineurin binding protein 1 (CBP1) have been demon-
strated to be upregulated by calcineurin and Crz1 in S. cerevisiae and
by Crz1 in M. oryzae (Kim et al. 2010; Yoshimoto et al. 2002), it was
not regulated by C. glabrata calcineurin and Crz1. Our transcript
proﬁling data suggest that the heat shock response genes (SBA1 and
GRE2) regulated by calcineurin and Crz1 may be involved in control-
ling thermal stress tolerance in C. glabrata. Consistent with a recent
study that CgYPS1 was regulated by Cnb1 and Crz1 in C. glabrata
(Miyazaki et al. 2011b), our microarray data support this ﬁnding and
provide a comprehensive view of the transcriptome regulated by the
calcineurin pathway. Real-time RT-PCR analysis conﬁrmed that the
transcription of CNA1 and CRZ1 was abolished in the cna1 and crz1
mutants, respectively (Figure 9B). The transcription of two control
genes (YPS5 and RCN2) determined by real-time RT-PCR was well
correlated with the microarray data (Figure 9C).
Rcn2 is a feedback inhibitor of calcineurin signaling
Regulator of calcineurin 2 (RCN2/YOR220w)w a sﬁrst identiﬁed a
decade ago in S. cerevisiae with a genetic screen for endogenous
inhibitors of calcineurin (Kingsbury and Cunningham 2000). The
transcription of ScRCN2 is activated by calcineurin and Crz1 (Mehta
et al. 2009). In C. albicans, microarray data showed that the transcrip-
tion of CaRCN2 (IPF12084/ORF19.6554, function uncharacterized)
Figure 7 Calcineurin is required
for azole and echinocandin toler-
ance in C. glabrata. (A, B) Calci-
neurin mutants are hypersensitive
to azoles and echinocandins.
Cells were grown overnight in
YPD at 24 , 5-fold serially diluted,
spotted onto YPD medium con-
taining ﬂuconazole (FLC), posaco-
nazole (PSC), ketoconazole (KTC),
micafungin (MCF), caspofungin
(CSF), or anidulafungin (ANF),
and incubated at 24  for 48 hr.
(C, D) Disk diffusion assays were
used to determine ﬂuconazole
and micafungin susceptibility of
wild-type and mutant strains.
Cells were grown overnight at
24 ,a n d0 . 1O D 600 (in 100 ml)
was spread on the surface of
YPD medium. A disk containing
20 mgo fﬂuconazole (C) or 50
ng of micafungin (D) was placed
on the surface of the medium.
The plates were incubated at 24 
for 24 hr. (E, F) Time-killing curve
of wild-type and cna1 (YC98),
cnb1 (YC193), and crz1 (YC182)
mutants in YPD medium 6 ﬂuco-
nazole (E) or micafungin (F). The
experiments were performed at
24 . The data are represented
as means 6 SD from triplicate
experiments.
Figure 8 Genome-wide analysis of calcineurin- and Crz1-dependent
targets in C. glabrata. Strains were grown overnight at 24  and washed
twice with dH2O. Cells were diluted to 0.2 OD/ml in YPD and incubated
at 24  for 3 hr. For the wild-type strain, cells in log-phase were diluted to
0.2 OD/ml (10 ml) in YPD in the presence or absence of FK506 (1 mg/ml).
cna1 (YC98) and crz1 (YC182) mutants were diluted to 0.2 OD/ml (10 ml)
in YPD. Following 3 hr incubation at 37 /250 rpm, cells were collected for
total RNA extraction, microarray experiments, and subsequent analysis.
(A) Calcineurin pathway up- and downregulated genes in a C. glabrata
wild-type strain treated with FK506, cna1,a n dcrz1 mutants. (B) The over-
laps between regulated genes for an FK506-treated wild-type strain,
cna1,a n dcrz1 mutants are depicted as Venn diagrams.
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et al. 2006). Miyazaki et al. (2011a) recently showed that transcription
of CgRCN2 was regulated by C. glabrata Cnb1 and Crz1. According to
our microarray analysis and real-time RT-PCR, we independently
demonstrated that the transcription of CgRCN2 was strongly activated
by Cna1 and Crz1 in C. glabrata. To test whether Rcn2 is a down-
stream target of calcineurin and Crz1, we constructed rcn2 mutants
and found that calcineurin-controlled cellular functions, such as ther-
motolerance, drug tolerance, ER stress, and pH homeostasis, were not
affected by deletion of RCN2 (Figure 10, A and B), indicating that
Rcn2 is not a functional target of calcineurin in C. glabrata. Instead,
we found that rcn2 mutants were hypersensitive to Ca2+ (Figure 10, A
and C), in contrast to the modestly increased Ca2+ tolerance of calci-
neurin mutants (Figure 10D, left panel). In S. cerevisiae, cells lacking
calcineurin grow better in the presence of high concentrations of Ca2+
compared with wild-type cells (Cunningham and Fink 1994; Withee
et al. 1998). This result suggests that inhibition of Ca2+ tolerance by
calcineurin is conserved in S. cerevisiae and C. glabrata. In contrast, C.
albicans and C. dubliniensis calcineurin mutants are hypersensitive to
Ca2+ (Chen et al. 2011; Sanglard et al. 2003), suggesting a divergent
role of calcineurin in Ca2+ tolerance between C. albicans/C. dublin-
iensis and C. glabrata/S. cerevisiae. The modestly increased Ca2+ tol-
erance of calcineurin mutants suggests that calcineurin represses Ca2+
tolerance in C. glabrata (Figure 11). The mechanisms by which genes
control calcium tolerance are unclear in C. glabrata.V a c u o l a rC a 2+
ATPase (Pmc1) and vacuolar Ca2+/H+ exchanger (Vcx1) are required
for calcium tolerance in S. cerevisiae (Cunningham and Fink 1996);
therefore, we hypothesize that the homologs of S. cerevisiae Pmc1
and Vcx1 also control calcium tolerance in C. glabrata, and it is possible
that calcineurin inhibits Pmc1 or Vcx1 via dephosphorylation in C.
glabrata. Interestingly, Ca2+ can rescue the temperature-sensitive
growth of C. glabrata calcineurin mutants at 40  (Figure 10D, right
panel), indicating that Ca2+ may activate a speciﬁc signaling cascade
that supports growth at an elevated temperature.
In S. cerevisiae, Rcn2 can inhibit calcineurin activity, and trunca-
tion mutations that removed the P·I·IT-like motif [P/G]·[I/V]·[I/V/L]
[E/D/N/H/T] of Rcn2 abolished its inhibition of calcineurin signaling
(Mehta et al. 2009). We found that C. glabrata and C. albicans Rcn2
also has a P·I·IT-like motif (Figure S6B), indicating calcineurin
inhibition mediated by Rcn2 might be conserved in these three
species. Interestingly, the T··P motif required for calcineurin stim-
ulation found in ScRcn1 and CgRcn1 is not found in CaRcn1 (Figure
S6A) or in Rcn2 of S. cerevisiae, C. glabrata, and C. albicans (Figure
S6). The synteny analysis of Rcn1 and Rcn2 in S. cerevisiae, C.
glabrata, and C. albicans suggests that C. albicans calcineurin regu-
lators are diverged from S. cerevisiae and C. glabrata (Figure S7).
The opposite phenotypes between rcn2 and calcineurin mutants in
response to Ca2+ led us to hypothesize that Rcn2 might serve as
Figure 9 Genes regulated by the calcineurin pathway in
C. glabrata. (A) List of 34 genes regulated by calcineurin
and Crz1. There are 30 genes that were upregulated by
calcineurin and Crz1, 3 genes downregulated by calci-
neurin and Crz1, and 1 gene (LIP5) upregulated by cal-
cineurin but downregulated by Crz1. The criteria used
to classify genes as upregulated or downregulated in
the microarray experiments is a cutoff Q value ,
0.001. (B) The transcription of CNA1 and CRZ1 was
abolished in the cna1 (YC98) and crz1 (YC182) mutants,
respectively. Real-time RT-PCR was used to measure the
expression level of each gene. (C) Real-time RT-PCR was
used to independently assess the expression levels
detected in microarray analyses for YPS5 and RCN2 in
wild-type, FK506-treated wild-type, cna1 mutant (YC98),
and crz1 mutant (YC182). Statistically signiﬁcant differ-
ences (P , 0.05 based on ANOVA, Bonferroni’s multiple
comparison tests) compared with the wild-type are in-
dicated by the asterisks.
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esis, we generated a set of calcineurin pathway and rcn2 double
mutants. The cna1 rcn2 and cnb1 rcn2 (but not crz1 rcn2) double
mutants exhibited a reversal of the Ca2+ hypersensitivity of the rcn2
mutant, and the addition of FK506 to Ca2+-containing media also
rescued the growth of rcn2 mutants (Figure 10C). Taken together,
our data suggest that Rcn2 serves as a negative regulator of calcineurin
and that calcineurin suppresses calcium tolerance in C. glabrata (Fig-
ure 10D). Interestingly, Rcn2 is not required for virulence in a murine
systemic infection model (Figure 10E).
Rcn1 controls cellular functions similar to calcineurin
in C. glabrata
Regulator of calcineurin 1 (Rcn1) was ﬁrst identiﬁed in fungi (Gorlach
et al. 2000; Kingsbury and Cunningham 2000) and mammals (Fuentes
et al. 2000; Rothermel et al. 2000) on the basis of its ability to interact
with and inhibit calcineurin when overexpressed. In S. cerevisiae,R c n 1
can also stimulate calcineurin signaling (Kingsbury and Cunningham
2000). Rcn1 was independently identiﬁed as Cbp1 in a screen for
calcineurin-binding proteins in C. neoformans and shown to be re-
quired for full virulence in a murine systemic infection model
(Gorlach et al. 2000). In C. albicans, Rcn1 (Ipf13909/Orf19.7770)
controls cell membrane integrity and azole tolerance, but not patho-
genicity, in murine systemic infection and oropharyngeal candidiasis
models (Reedy et al. 2009). In contrast to S. cerevisiae (Yoshimoto
et al. 2002), we found that calcineurin and Crz1 do not transcription-
ally regulate Rcn1 in C. glabrata. It is possible that Rcn1 physically
interacts with calcineurin to regulate calcineurin signaling. Thus, Rcn1
and calcineurin may act on shared downstream targets. Miyazaki et al.
(2011a) recently showed that Rcn1 controls ER stress response and
drug tolerance in C. glabrata.O u rrcn1 mutants exhibited similar
phenotypes and have additional phenotypes, such as hypersensitive
growth to altered pH (acidic and alkaline) and elevated temperature
(41 ) (Figure 10, A and B), and modest resistance to Ca2+ (Figure
10A). Unlike C. neoformans cbp1 mutants, C. glabrata rcn1 mutants
did not exhibit attenuated virulence compared with the wild-type
strain in a murine systemic infection model (Figure 10E). Overall,
calcineurin mutants exhibit more severe phenotypes than rcn1
mutants, suggesting that Rcn1 is only partially required for calcineurin
function. The rcn1 rcn2 double mutant had a virulence level similar to
the wild-type strain(P ¼ 0.1 inspleen; P ¼ 0.47in kidney) in a murine
systemic infection model (Figure 10E) and exhibited phenotypes sim-
ilar to the rcn1 mutant. This indicates that rcn1 mutation is epistatic to
the rcn2 mutation in C. glabrata. Rcn1 may play a larger role in
maintaining calcineurin signaling than the role of Rcn2 in calcineurin
inhibition.
Figure 10 Divergent roles of the calcineurin signaling
cascade in stress responses. (A) Rcn2 and Rcn1 have
divergent roles in stress responses. Strain preparations
were carried out as described above. The plates were
incubated at 30  for 48 hr. Strains tested were wild-type
(CBS138), rcn2 mutants (YC525 and YC531), rcn1
mutants (YC553 and YC556), and the rcn2 rcn1 double
mutant (YC594). (B) Rcn1 contributes to thermotoler-
ance. The plates were incubated at temperatures indi-
cated for 24 hr. (C) Rcn2 acts as a negative regulator of
calcineurin signaling in response to calcium stress.
Strains spotted onto YPD medium 6 CaCl2 (0.4 M)
and/or FK506 (1 mg/ml) were incubated at 30  for 48
hr. (D) Calcineurin mutants exhibit modest resistance to
calcium stress and are rescued by calcium at elevated
temperatures. Cells were grown overnight in YPD at
24 , 5-fold serially diluted, spotted onto YPD medium
in the absence or presence of 0.4 M CaCl2, and incu-
bated at the indicated temperatures for 48 hr. (E) The
fungal burden in the spleens and kidneys was deter-
mined on day 7 after challenge with 4 · 107 C. glabrata
wild-type or mutant cells (in 200 ml) via lateral tail vein
injection. Ten male CD1 mice per strain were used.
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calcipressin) is preferentially expressed in the brain of patients with
Down’s syndrome and contributes to tumor suppression, suggesting
DSCR1 could be explored as a potential therapeutic target (Baek et al.
2009). The difference in virulence of C. neoformans cbp1 and
C. glabrata rcn1 mutants suggests a divergent role of Cbp1/Rcn1 in
controlling pathogenicity between C. neoformans and C. glabrata.O u r
data also showed that Rcn1 controls azole and echinocandin tol-
erance (Figure 10A), making drug combination therapy with yet-
to-be-developed Rcn1 inhibitors and azoles or echinocandins possible
approaches to target emerging C. glabrata infections.
CONCLUSIONS
We have demonstrated in this study that calcineurin and Crz1
contribute to the control of thermotolerance, ER stress response,
echinocandin tolerance, cell membrane integrity, and pathogenesis in
C. glabrata (Figure 11). In addition, calcineurin, but not Crz1, con-
tributes to pH homeostasis, serum growth, and azole tolerance (Figure
11). In contrast to C. albicans, C. glabrata calcineurin modestly inhibits
calcium tolerance, suggesting a divergent role of calcineurin in governing
calcium tolerance between C. glabrata and C. albicans.U n l i k et h er o l eo f
Crz1 as the positive regulator that controls azole tolerance in C. albicans,
C. glabrata Crz1 acts as a negative regulator of azole tolerance (Figure
11), indicating rewiring of this transcription factor among Candida
species. The calcineurin regulator Rcn1 positively regulates calcineurin
functions, including thermotolerance, ER stress response, and echino-
candin tolerance, but not cell membrane integrity and virulence. The
other calcineurin regulator, Rcn2, acts as a feedback inhibitor of calci-
neurin signaling (Figure 11). In the future, determining how calcineurin
interacts with other signaling pathways to control core stress responses
and how Rcn1 and Rcn2 interact with calcineurin will contribute to our
understanding of calcineurin biology and signal transduction.
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